Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Roberts

Showing results (1-10 of 182) with videos related to

Pageof 19
Sort By:
JAMA|January 1, 1988
Induction of immune tolerance to factor VIII: a plea for cautionH R Roberts
Vox Sanguinis|October 26, 1999
The use of agents that by-pass factor VIII inhibitors in patients with haemophiliaH R Roberts
The New England Journal of Medicine|September 3, 1970
Acquired inhibitors to factor IXH R Roberts
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 1, 2010
10th Novo Nordisk Symposium on Haemostasis Management--introductionH R Roberts
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Choice of replacement therapy for hemophiliaH R Roberts
Cellular and Molecular Life Sciences : CMLS|January 27, 2007
Contributions to the evolution of knowledge about hereditary hemorrhagic disordersH R Roberts
Western Journal of Medicine and Surgery|January 11, 2024
A Case of Functional, Simulating Organic Disease of the HeartH R Roberts
Annals of the New York Academy of Sciences|January 1, 1991
Factor VIII replacement therapy. Issues and future prospectsH R Roberts
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1994
A comparison of the European Accord and the Recommendations of the American National Hemophilia FoundationH R Roberts
Seminars in Hematology|December 6, 2001
Recombinant factor VIIa (Novoseven) and the safety of treatmentH R Roberts
Pageof 19

Showing results (1-10 of 182) with videos related to

Sort By:
Pageof 19
JAMA|January 1, 1988
Induction of immune tolerance to factor VIII: a plea for cautionH R Roberts
Vox Sanguinis|October 26, 1999
The use of agents that by-pass factor VIII inhibitors in patients with haemophiliaH R Roberts
The New England Journal of Medicine|September 3, 1970
Acquired inhibitors to factor IXH R Roberts
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 1, 2010
10th Novo Nordisk Symposium on Haemostasis Management--introductionH R Roberts
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Choice of replacement therapy for hemophiliaH R Roberts
Cellular and Molecular Life Sciences : CMLS|January 27, 2007
Contributions to the evolution of knowledge about hereditary hemorrhagic disordersH R Roberts
Western Journal of Medicine and Surgery|January 11, 2024
A Case of Functional, Simulating Organic Disease of the HeartH R Roberts
Annals of the New York Academy of Sciences|January 1, 1991
Factor VIII replacement therapy. Issues and future prospectsH R Roberts
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1994
A comparison of the European Accord and the Recommendations of the American National Hemophilia FoundationH R Roberts
Seminars in Hematology|December 6, 2001
Recombinant factor VIIa (Novoseven) and the safety of treatmentH R Roberts
Pageof 19